High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis [10] Journal Article


Authors: Comenzo, R. L.; Steingart, R. M.; Cohen, A. D.
Article Title: High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis [10]
Keywords: treatment outcome; mortality; monotherapy; multimodality cancer therapy; note; combined modality therapy; drug megadose; letter; treatment indication; morbidity; combination chemotherapy; dexamethasone; melphalan; amyloidosis; stem cell transplantation; hematopoietic stem cell transplantation; immunoglobulin light chain; immunoglobulin light chains; granulocyte colony stimulating factor; myeloablative agonists; myeloablative agent
Journal Title: New England Journal of Medicine
Volume: 358
Issue: 1
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2008-01-03
Start Page: 92
Language: English
PUBMED: 18175384
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 17 November 2011" - "CODEN: NEJMA" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Adam D Cohen
    44 Cohen
  2. Raymond L Comenzo
    115 Comenzo
  3. Richard M Steingart
    174 Steingart